[go: up one dir, main page]

ZA200007258B - Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders. - Google Patents

Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders.

Info

Publication number
ZA200007258B
ZA200007258B ZA200007258A ZA200007258A ZA200007258B ZA 200007258 B ZA200007258 B ZA 200007258B ZA 200007258 A ZA200007258 A ZA 200007258A ZA 200007258 A ZA200007258 A ZA 200007258A ZA 200007258 B ZA200007258 B ZA 200007258B
Authority
ZA
South Africa
Prior art keywords
norcisapride
bulimia
disorders
optically pure
treating apnea
Prior art date
Application number
ZA200007258A
Inventor
Paul D Rubin
Timothy J Barberich
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of ZA200007258B publication Critical patent/ZA200007258B/en

Links

ZA200007258A 1998-06-15 2000-12-07 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders. ZA200007258B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8922498P 1998-06-15 1998-06-15

Publications (1)

Publication Number Publication Date
ZA200007258B true ZA200007258B (en) 2001-06-07

Family

ID=27753962

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200007258A ZA200007258B (en) 1998-06-15 2000-12-07 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders.

Country Status (1)

Country Link
ZA (1) ZA200007258B (en)

Similar Documents

Publication Publication Date Title
PL345275A1 (en) Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
ZA993364B (en) Novel 4-phenylpiperidines for the treatment of pruritic dermatoses.
PL330496A1 (en) Methods of and compositions for treating and preventing tumours, disorders associated with tumours as well as cachexy
HUP9900163A3 (en) Process for the preparation of sterol-and stanol-esters, and use thereof
AU4060599A (en) Pharmaceutical composition for treating or preventing sleep disorders
ZA989667B (en) The use of MMP-13 selective inhibitors for the treatment of osteoarthritis and other MMP-mediated disorders.
IL142900A0 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
ZA978842B (en) Use of an H<+>, K<+>-ATPase inhibitor in the treatment of nasal polyps.
ZA986363B (en) Novel method of treatment.
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
ZA985237B (en) Novel method of treatment.
PL345325A1 (en) Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
AU7595298A (en) Azolidinediones useful for the treatment of diabetes, dyslipidemia and hy pertension
ZA986364B (en) Novel method of treatment.
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
ZA986365B (en) Novel method of treatment.
ZA973843B (en) Treatment of asthma with TNFR-lg.
HUP0102772A3 (en) Novel compounds derived from alpha-d-xylose, preparation method and therapeutic use
ZA200007258B (en) Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders.
AU5974999A (en) Hair treatment composition, method and use
ZA200007396B (en) Method of treatment.
ZA200007259B (en) Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders.
ZA200006166B (en) Substituted sulphonyl cyanamides, method for producing same and their use as medicament.
AU5330599A (en) Methods and compositions for treating and preventing certain psychiatric and medical disorders using moclobemide
AU1977497A (en) Methods of treating or preventing sleep apnea